UAB receives $3.5 million grant for eye care outreach

UAB has received a five-year, $3.5 million grant to study strategies to detect and manage glaucoma and other eye diseases in community-based settings. This grant will be focused on populations that are most at risk and the least likely to have access to eye care. The grant has been awarded to Lindsay Rhodes, assistant professor in the Department of Ophthalmology and Visual Sciences. The research plan seeks to implement and evaluate a telemedicine-based strategy in patients that are primarily treated…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news

Related Links:

Conclusions: DM suturing can reattach DM, especially in moderate to severe, recurrent DMD with fewer postoperative complications and thereby reduce the need for corneal transplantation.
Source: Cornea - Category: Opthalmology Tags: Clinical Science Source Type: research
Authors: Li HY, Rong SS, Hong X, Guo R, Yang FZ, Liang YY, Li A, So KF Abstract  Many ocular diseases (such as glaucoma, diabetic retinopathy, age-related macular degeneration, and traumatic eye injuries) can result in the degeneration of retinal cells and the subsequent loss of vision. Some kinds of treatments, such as drugs, stem cell transplantation and surgery are reported to be effective in certain patients. However, no confirmatively effective, convenient and low-price intervention has been available so far. Physical exercise has been reported to exert neuroprotective effects on several neurodegenerative...
Source: Restorative Neurology and Neuroscience - Category: Neurology Tags: Restor Neurol Neurosci Source Type: research
ConclusionThe proportional difference between the permanently impaired and the non-permanently impaired was higher in work tool-related eye injuries than other causes reported in previous Helsinki Ocular Trauma Studies. High-risk injuries were mainly caused by manual tools and nails and resulted in OGI.
Source: International Ophthalmology - Category: Opthalmology Source Type: research
Conditions:   Cataract;   Age-related Cataract;   Circadian Rhythm Disorders;   Glaucoma;   Age Related Macular Degeneration Interventions:   Device: Blue-light filtering intraocular lens;   Device: Conventional intraocular lens Sponsor:   University of Pittsburgh Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Open Angle Glaucoma Interventions:   Biological: 2.5mg ANX007;   Biological: 5.0mg ANX007;   Other: Sham Procedure Sponsor:   Annexon, Inc. Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Cataract;   Age-related Cataract;   Circadian Rhythm Disorders;   Glaucoma;   Age Related Macular Degeneration Interventions:   Device: Blue-light filtering intraocular lens;   Device: Conventional intraocular lens Sponsor:   University of Pittsburgh Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Open Angle Glaucoma Interventions:   Biological: 2.5mg ANX007;   Biological: 5.0mg ANX007;   Other: Sham Procedure Sponsor:   Annexon, Inc. Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
CONCLUSION: We conclude that chronic topical timolol administration may aggravate a cardiac conduction defect leading to an AV block that is only temporarily resolved by timolol cessation. Patients taking timolol should be routinely monitored for cardiovascular aberrations and if any detected, immediately discontinue timolol therapy. Individuals experiencing timolol induced cardiovascular side effects should receive long term follow-up even if symptoms resolve, as they may be indicative of an underlying conduction defect. PMID: 31791399 [PubMed - in process]
Source: BMC Pharmacology and Toxicology - Category: Drugs & Pharmacology Tags: BMC Pharmacol Toxicol Source Type: research
XEN Gel Stent, REF 5513-001(US Model), Sterile, RX Only, (01)10888628032439 ; Other Model Numbers: 5507-001(Global Model) and 5517-001(Australia model) Implant for glaucoma treatment.
Source: Medical Device Recalls - Category: Medical Devices Source Type: alerts
Management of many eye diseases depends on proper compliance of patients with the use of prescribed medication, which includes proper instillation of eye drops. The diseases include acute and chronic conditions including glaucoma, dry eyes and infectious keratitis which need long term use of topical eye drops [1,2]. Clinical outcome of any disease depends on proper and successful instillation of eye drops. Incorrect ways of putting drops may result in eye injury, abrasion, congestion of the eye, allergic skin reaction and also contamination of eye drops [3].
Source: Contact Lens and Anterior Eye - Category: Opthalmology Authors: Source Type: research
More News: Biotechnology | Glaucoma | Grants | Health Management | Opthalmology | Study